
4bases’ Paper of The Month – December 2025 – A clinical validation of the Oxford Nanopore Technologies LRS performance with the 4bases compatible CE-IVD panels HEVA pro, CARDIO pro, BRaCA, and ClinEX Pro in genetically heterogeneous disorders
Genetic testing has advanced enormously in the past decade, mainly thanks to short-read sequencing (SRS) technologies – such as Illumina platforms – which read DNA